- Home
- /
- Drugs
- /
- E
- /
- Erythromycin
- /
- Erythromycin ERYTHROMYCIN 5 mg/g Fera Pharmaceuticals, LLC
Erythromycin
- Erythromycin ERYTHROMYCIN 5 mg/g Asclemed USA, Inc.
- Erythromycin ERYTHROMYCIN 5 mg/g Proficient Rx LP
- Erythromycin ERYTHROMYCIN 5 mg/g ARMAS PHARMACEUTICALS INC.
- Erythromycin ERYTHROMYCIN 5 mg/g Fera Pharmaceuticals, LLC
- Erythromycin ERYTHROMYCIN 5 mg/g Asclemed USA, Inc.
- Erythromycin ERYTHROMYCIN 5 mg/g REMEDYREPACK INC.
- Erythromycin ERYTHROMYCIN 5 mg/g A-S Medication Solutions
- Erythromycin ERYTHROMYCIN 5 mg/g RPK Pharmaceuticals, Inc.
- Erythromycin ERYTHROMYCIN 5 mg/g REMEDYREPACK INC.
- Erythromycin ERYTHROMYCIN 5 mg/g Preferred Pharmaceuticals Inc.
- Erythromycin ERYTHROMYCIN 5 mg/g A-S Medication Solutions
- Erythromycin ERYTHROMYCIN 5 mg/g Proficient Rx LP
- Erythromycin ERYTHROMYCIN 5 mg/g Proficient Rx LP
- Erythromycin ERYTHROMYCIN 5 mg/g A-S Medication Solutions
- Erythromycin ERYTHROMYCIN 5 mg/g NuCare Pharmaceuticals,Inc.
- Erythromycin ERYTHROMYCIN 5 mg/g Cardinal Health 107, LLC
- Erythromycin ERYTHROMYCIN 5 mg/g NuCare Pharmaceuticals,Inc.
- Erythromycin ERYTHROMYCIN 5 mg/g REMEDYREPACK INC.
- Erythromycin ERYTHROMYCIN 5 mg/g Bausch & Lomb Incorporated
- Erythromycin ERYTHROMYCIN 5 mg/g Asclemed USA, Inc.
Summary of product characteristics
Effective Time
20231026
Version
2
Spl Product Data Elements
Erythromycin Erythromycin ERYTHROMYCIN ERYTHROMYCIN MINERAL OIL PETROLATUM
Brand Name
Erythromycin
Generic Name
Erythromycin
Product Ndc
48102-057
Product Type
HUMAN PRESCRIPTION DRUG
Route
OPHTHALMIC
Package Label Principal Display Panel
Principal Display Panel - 5 mg Carton Label (Steri-Med) Sterile Sterile 50 x 1g unit dose tubes tubes unidose DIN 02326663 Pr ONGUENT OPHTALMIQUE D'ERYTHROMYCINE USP Pr ERYTHROMYCIN OPHTHALMIC OINTMENT USP 5 MG/G ANTIBIOTIC / ANTIBIOTIQUE Steri-Med Pharma Principal Display Panel - 5 mg Carton Label (Steri-Med)
Drug section
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.
Disclaimer
The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).
Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.
Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.